The GLP is committed to full transparency. Download and review our Annual Report.

Trump executive order streamlining biotech rules won’t speed CRISPR animal approvals, livestock industry says

| | June 26, 2019

The executive order that the Trump administration announced [in June 2019] to streamline the approval process for agricultural biotechnology has not offered the regulatory relief that the livestock industry was hoping for, said officials from the National Pork Producers Council [June 25].

The order calls for a review of existing regulations and exemptions for certain “low-risk” agricultural products where statutorily possible.

Crops fall under the purview of the U.S. Department of Agriculture, which has developed a standardized evaluation and approval process. But, gene-edited livestock — like disease-resistant pigs and hornless cattle — are regulated by the Food and Drug Administration, which classifies such animals as “drugs” and the farms that raise them as drug manufacturers.

Related article:  CRISPR treatment for dogs with muscular dystrophy could one day lead to a cure for humans

The agricultural industry warns that once gene-edited animals become more prevalent globally, the U.S. will be at a competitive disadvantage if its farmers are waiting around for approval.

Read full, original article: Livestock industry pushes for more changes to rules on gene-edited animals (Behind Paywall)

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend